Dalvance 500 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F7XLM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,854
Award facts
- Contract value 100% obligated
- $8,854.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued an $8,854.30 delivery order to Amerisourcebergen Drug Corp on May 4, 2026, for Dalvance 500 mg vials, a specialty antibiotic pharmaceutical product.
Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with an ultimate completion date of May 5, 2026. No set-aside was used. The order was issued under a DLA Troop Support Medical indefinite delivery contract supporting pharmaceutical distribution to Defense Health Agency and military medical facilities.
Quick answers
Who was awarded contract SPE2DR26F7XLM?
SPE2DR26F7XLM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 4, 2026.
How much is contract SPE2DR26F7XLM worth?
The government has obligated $8,854 on SPE2DR26F7XLM.
Is contract SPE2DR26F7XLM an order under another contract?
Yes. SPE2DR26F7XLM is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7XLM competed?
The extent of competition for SPE2DR26F7XLM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award